Rani Therapeutics Holdings (RANI) Minority Interest (2021 - 2026)

Rani Therapeutics Holdings' Minority Interest history runs 6 years deep, the most recent figure standing at $7.1 million for Q1 2026.

• On a quarterly basis, Minority Interest rose 411.3% year-over-year to $7.1 million in Q1 2026; TTM through Mar 2026 was $7.1 million, a 411.3% increase from a year earlier, with the FY2025 full-year figure at $8.5 million, up 466.42% from the prior year.
• Minority Interest fell to $7.1 million in Q1 2026 per RANI's latest filing, from $8.5 million in the prior quarter.
• Across five years, Minority Interest topped out at $57.3 million in Q1 2022 and bottomed at -$4.1 million in Q3 2025.
• The 5-year median for Minority Interest is $8.5 million (2025), against an average of $17.3 million.
• Biggest YoY gain for Minority Interest was 466.42% in 2025; the steepest drop was 254.92% in 2025.
• Year by year, Minority Interest stood at $37.1 million in 2022, then plunged by 66.14% to $12.6 million in 2023, then sank by 88.07% to $1.5 million in 2024, then soared by 466.42% to $8.5 million in 2025, then declined by 16.04% to $7.1 million in 2026.
• Per Business Quant, the three latest RANI Minority Interest figures stand at $7.1 million (Q1 2026), $8.5 million (Q4 2025), and -$4.1 million (Q3 2025).